- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06316362
Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine
Study Overview
Detailed Description
Among anticonvulsants, carbamazepine (CBZ) is considered one of the most commonly reported poisonings. Carbamazepine (CBZ) was approved for use as a primary anticonvulsant agent following its initial use for trigeminal neuralgia. Further indications for the drug included treatment for bipolar disorder, resistant schizophrenia, and pain syndromes.
The wide availability of carbamazepine increases the potential for overdose, either accidentally or intentionally. The American Association of Poison Control Centres reported 2,562 hazardous exposures to CBZ in 2020. In addition, CBZ was the most commonly used anti-epileptic drug, according to a recent study by the National Centre for Environmental and Clinical Toxicology Research, Cairo, Egypt.
CBZ works by blocking presynaptic voltage-gated sodium channels, thereby inhibiting the release of synaptic glutamate and other neurotransmitters.
Overdose of CBZ is clinically manifested by nystagmus, nausea, dysarthria, ataxia, sedation, delirium, mydriasis, ophthalmoplegia, and myoclonus. The serious clinical problems resulting from large overdoses of CBZ are cardiotoxicity, respiratory depression, apnea, seizures, and coma. Mortality from CBZ poisoning is uncommon.
Because there is no definitive antidote for carbamazepine poisoning, poison control centres recommend supportive therapy based on the patient's clinical condition and multiple-dose activated charcoal (MDAC) as a specific intervention for enhanced elimination. Nevertheless, the elimination of the drug from the body can be prolonged.
The scarcity of physiological antidotes for acute poisonings encourages toxicologists to supplement standard supportive treatment protocols with promising agents that tend to improve morbidity and mortality.
In this context, intravenous lipid emulsions (ILE) are mainly used as a source of energy and essential fatty acids in patients requiring parenteral nutrition. Apart from their nutritional value, lipid emulsion therapy is becoming increasingly popular in critical care settings as a treatment for toxicity with lipophilic agents, particularly when the standard remedies are ineffective.
Following the encouraging outcomes of using ILEs for the treatment of local anaesthetic systemic toxicity, subsequent studies reported the therapeutic effect of ILEs in acute poisonings with other xenobiotics. However, the evidence for the potential effectiveness of ILE in clinical toxicology consists mainly of case reports and experimental studies. In cases of CBZ poisoning, ILE was not evaluated using a randomised control trial (RCT).
ILE may be suitable for the treatment of CBZ toxicity due to its lipid solubility. To the best of our knowledge, the effect of ILE therapy on acute carbamazepine poisoning has not been studied sufficiently.
SMOF 20%, a blend of soybean oil, medium-chain triglycerides, olive oil, and fish oil, is a new lipid emulsion product that has shown better therapeutic results regarding parentral nutrition when compared with traditional ones such as Intralipid® 20%. It has been associated with decreased oxidative injury, improved liver function, and increased antioxidant activity
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt
- Faculty of medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
The patients were enrolled in the study in accordance with the following:
- Gender and age: adult symptomatic males and females.
- Patients were admitted within 12 hours of exposure to the poison.
- Patients received no prior treatment before admission.
- Patients with moderate-to-severe carbamazepine poisoning according to the Poisoning Severity Score (PSS)
- Patients classified as high-risk (HR) with anti-depressant overdose risk assessment (ADORA) criteria.
Exclusion Criteria:
Patients will be excluded if they have any of the following conditions:
- pregnant and lactating women.
- Patients with major medical conditions (e.g. diabetes mellitus), cardiovascular disease, renal, or hepatic failure).
- Patients suffering from hyperlipidemia.
- Malignancy.
- Co-ingestion.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: control group
The first group constitutes the control group that was administered the standard treatment protocol for carbamazepine toxicity.
|
SMOF 20%; a blend of (soybean oil, medium chain triglycerides, olive and fish oil) is a new lipid emulsion product that was provided as a bolus dose of 1.5ml/kg for one hour, followed by a maintenance dose of 6 ml/kg for a period of four hours to the active comparator group
|
Active Comparator: SMOF lipid treated group
The second group received the SMOF lipid infusion in addition to the standard protocol.
|
SMOF 20%; a blend of (soybean oil, medium chain triglycerides, olive and fish oil) is a new lipid emulsion product that was provided as a bolus dose of 1.5ml/kg for one hour, followed by a maintenance dose of 6 ml/kg for a period of four hours to the active comparator group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improvement in Conscious Levels Measured by Glasgow Coma Scale (GCS)
Time Frame: participants were monitored within 24 hours from admission to the hospital
|
This study evaluates the efficacy of SMOF lipid 20% in improving conscious levels among participants with acute carbamazepine poisoning within 24 hours.
Conscious level improvement is assessed using the Glasgow Coma Scale (GCS), a widely recognised tool for neurological assessment.
The GCS measures eye opening, verbal response, and motor response, with higher scores indicating better conscious levels.
The study aims to determine the extent of improvement in GCS scores following SMOF lipid administration, providing valuable insights into its effectiveness in enhancing neurological function.
|
participants were monitored within 24 hours from admission to the hospital
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of Intubation Requirement Using GCS and APACHE
Time Frame: participants were assessed within 24 hours from admission to the hospital
|
This study investigates the requirement for intubation and mechanical ventilation among participants with acute carbamazepine poisoning using multiple clinical assessment tools, including the Glasgow Coma Scale (GCS) and Acute Physiology and Chronic Health Evaluation (APACHE).
The GCS evaluates the level of consciousness based on eye opening, verbal response, and motor response, with lower scores indicating a higher likelihood of intubation and mechanical ventilation.
The APACHE score assesses the severity of illness and predicts the need for respiratory support, with higher scores indicating an increased risk of respiratory failure and the requirement for intervention.
|
participants were assessed within 24 hours from admission to the hospital
|
Length of Intensive Care Unit (ICU) Stay
Time Frame: Participants will be monitored throughout their hospitalisation period, and the length of their ICU stay will be recorded from date of randomization until the date of last documented progression up to one month
|
This study evaluates the length of stay in the Intensive Care Unit (ICU) among participants with acute carbamazepine poisoning.
The length of the ICU stay is defined as the duration from the time of admission to the ICU to discharge from the ICU in days.
Participants will be monitored throughout their hospitalisation period, and the length of their ICU stay will be recorded.
The study aims to assess the impact of SMOF lipid administration on the duration of ICU stays, providing insights into its effectiveness in optimising resource utilisation and patient management.
Understanding the factors influencing the length of the ICU stay may contribute to improved healthcare delivery and patient outcomes in acute carbamazepine poisoning.
|
Participants will be monitored throughout their hospitalisation period, and the length of their ICU stay will be recorded from date of randomization until the date of last documented progression up to one month
|
length of hospital stay
Time Frame: Participants will be monitored throughout their hospitalisation period, and the length of their hospital stay will be recorded from date of randomization until the date of last documented progression up to one month
|
This study evaluates the length of stay in the hospital among participants with acute carbamazepine poisoning.
The length of stay is defined as the duration from the time of admission to the hospital to discharge from the hospital in days.
Participants will be monitored throughout their hospitalisation period, and the length of their hospital stay will be recorded.
The study aims to assess the impact of SMOF lipid administration on the duration of hospital stays, providing insights into its effectiveness in optimising resource utilisation and patient management.
Understanding the factors influencing length of stay may contribute to improved healthcare delivery and patient outcomes in acute carbamazepine poisoning.
|
Participants will be monitored throughout their hospitalisation period, and the length of their hospital stay will be recorded from date of randomization until the date of last documented progression up to one month
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Abeer Sheta, professor, Alexandria University
Publications and helpful links
General Publications
- Zyoud SH, Waring WS, Al-Jabi SW, Sweileh WM, Rahhal B, Awang R. Intravenous Lipid Emulsion as an Antidote for the Treatment of Acute Poisoning: A Bibliometric Analysis of Human and Animal Studies. Basic Clin Pharmacol Toxicol. 2016 Nov;119(5):512-519. doi: 10.1111/bcpt.12609. Epub 2016 May 20.
- Karaman K, Turkdogan KA, Deniz AT, Canakci SE. Which is the best in carbamazepine overdose? Clin Case Rep. 2017 Aug 22;5(10):1612-1615. doi: 10.1002/ccr3.1118. eCollection 2017 Oct.
- Jaffal K, Chevillard L, Megarbane B. Lipid Emulsion to Treat Acute Poisonings: Mechanisms of Action, Indications, and Controversies. Pharmaceutics. 2023 May 3;15(5):1396. doi: 10.3390/pharmaceutics15051396.
- Taftachi F, Sanaei-Zadeh H, Sepehrian B, Zamani N. Lipid emulsion improves Glasgow coma scale and decreases blood glucose level in the setting of acute non-local anesthetic drug poisoning--a randomized controlled trial. Eur Rev Med Pharmacol Sci. 2012 Mar;16 Suppl 1:38-42.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMOF in carbamazepine toxicity
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Poisoning
-
Peking Union Medical College HospitalThe Affiliated Hospital of Qingdao University; The First Affiliated Hospital... and other collaboratorsNot yet recruiting
-
Sohag UniversityNot yet recruitingAcute Poisoning
-
Giriraj HospitalCompletedStudy to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.Acute Organophosphorus Pesticide PoisoningIndia
-
Sohag UniversityNot yet recruiting
-
National Institute of Environmental Health Sciences...Health Canada; Danish Institute for Public Health; Indian and Northern Affairs...Completed
-
National Institute of Environmental Health Sciences...Completed
-
Amani Hassan Abdel-WahabNot yet recruitingOrganophosphorus Poisoning
-
Rigshospitalet, DenmarkCompletedCarbon Monoxide Poisoning From Fire AccidentsDenmark
-
Sir Salimullah Medical College Mitford HospitalRecruitingOrganophosphorus PoisoningBangladesh
-
Ankara City Hospital BilkentRecruitingCarbon Monoxide PoisoningTurkey
Clinical Trials on SMOF lipid 20%
-
The University of Texas Health Science Center,...CompletedPrematurityUnited States
-
Mansoura UniversityUnknownNeurological ComplicationsEgypt
-
Thammasat UniversityCompleted
-
Fresenius KabiCompletedParenteral NutritionAustralia, Denmark, France, Israel, Netherlands, Poland, United Kingdom
-
National Center for Tumor Diseases, HeidelbergHeidelberg UniversityTerminated
-
Fresenius KabiTerminatedHospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 DaysUnited States
-
Beth Israel Deaconess Medical CenterTerminatedHypertriglyceridemiaUnited States
-
Indiana UniversityActive, not recruitingComparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical NeonatesCholestasis of Parenteral NutritionUnited States
-
Fresenius KabiTerminatedMalnutrition, ChildUnited States